Abstract:Background: Hand-foot-and-mouth disease (HFMD) is caused mainly by the human enterovirus type 71 (HEV71) and the Coxsackievirus A group type 16 (CVA16). Large outbreaks of disease have occurred frequently in the Asia-Pacific region. Reliable methods are needed for diagnosis of HFMD in childen. IgM-capture ELISA, with its notable advantages of convenience and low cost, provides a potentially frontline assay. We aimed to evaluate the newly developed IgM-capture ELISAs for HEV71 and CVA16 in the diagnosis of HFMD, and to measure the kinetics of IgM over the course of HEV71 or CVA16 infections.Results: We mapped, for the first time, the kinetics of IgM in HEV71 and CVA16 infection. HEV71- and CVA16-IgM were both detectable in some patients on day 1 of illness, and in 100% of patients by day 5 (HEV71) and day 8 (CVA16) respectively; both IgMs persisted for several weeks. The IgM detection rates were 90.2% (138 of 153 sera) and 68.0% (66 of 97 sera) for HEV71 and CVA16 infections, respectively, during the first 7 days of diseases. During the first 90 days after onset these values were 93.6% (233 of 249 sera) and 72.8% (91 of 125 sera) for HEV71 and CVA16 infections, respectively. Some cross-reactivity was observed between HEV71- and CVA16-IgM ELISAs. HEV71-IgM was positive in 38 of 122 (31.1%) CVA16 infections, 14 of 49 (28.6%) other enteroviral infections and 2 of 105 (1.9%) for other respiratory virus infected sera. Similarly, CVA16-IgM was apparently positive in 58 of 211 (27.5%) HEV71 infections, 16 of 48 (33.3%) other enterovirus infections and 3 of 105 (2.9%) other respiratory virus infected sera. Nevertheless, the ELISA yielded the higher OD450 value of main antibody than that of cross-reaction antibody, successfully identifying the enteroviral infection in 96.6% (HEV71) and 91.7% (CVA16) cases. When blood and rectal swabs were collected on the same day, the data showed that the agreement between IgM-capture ELISA and real-time RT-PCR in HEV71 was high (Kappa value = 0.729) while CVA16 somewhat lower (Kappa value = 0.300).Conclusions: HEV71- and CVA16-IgM ELISAs can be deployed successfully as a convenient and cost-effective diagnostic tool for HFMD in clinical laboratories.

A Reverse Transcription-Polymerase Spiral Reaction (Rt-Psr)-based Rapid Coxsackievirus A16 Detection Method and Its Application in the Clinical Diagnosis of Hand, Foot, and Mouth Disease.

Rapid and Sensitive Identification of RNA from the Emerging Pathogen, Coxsackievirus A6

Highly sensitive and rapid identification of coxsackievirus A16 based on reverse transcription multiple cross displacement amplification combined with nanoparticle-based lateral flow biosensor assay

A multiplex one-step fluorescence quantitative differential diagnosis method for severe hand, foot and mouth disease caused by coxsackievirus A16

Rapid Detection of Human Adenovirus by Multiple Cross Displacement Amplification Combined with Nanoparticle-Based Biosensor Platform

Microchip Capillary Electrophoresis with Laser-Induced Fluorescence Combined with One-Step Duplex Reverse-Transcription Polymerase Chain Reaction for the Rapid Detection of Enterovirus 71 and Coxsackievirus A16 in Throat Swab Specimens.

Establishment of a Novel One-Step Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Rapid Identification of RNA from the Severe Fever with Thrombocytopenia Syndrome Virus.

Applicability of duplex real time and lateral flow strip reverse-transcription recombinase aided amplification assays for the detection of Enterovirus 71 and Coxsackievirus A16

A One-Step, Triplex, Real-Time RT-PCR Assay for the Simultaneous Detection of Enterovirus 71, Coxsackie A16 and Pan-Enterovirus in a Single Tube

Clinical analysis of detection of EV71,Cox A16 in children with hand-foot-mouth disease by real-time fluorescence quantitative PCR

Detection and Identification of Viral Pathogens in Patients with Hand, Foot, and Mouth Disease by Multilocus PCR, Reverse-Transcription PCR and Electrospray Ionization Mass Spectrometry.

[Development of EV71, CA16 and Other Enterovirus Vrial Real-Time Qualitative PCR Diagnostic Kit].

Simultaneous Detection of Human Enterovirus 71 and Coxsackievirus A16 in Clinical Specimens by Multiplex Real-Time PCR with an Internal Amplification Control

Development of a Coxsackievirus A16 Neutralization Test Based on the Enzyme-Linked Immunospot Assay.

Reverse Transcriptase Enzyme-assisted Recombinant Isothermal Amplification with CRISPR/Cpf1 for RNA Virus Assay

Simultaneous detection of enterovirus 70 and coxsackievirus A24 variant by multiplex real-time RT-PCR using an internal control.

[Simultaneous Detection of Enterovirus 71 and Coxsackievirus A16 by Multiplex Real-Time PCR with an Internal Control].

Establishment of Reverse Transcription Helicase-Dependent Isothermal Amplification for Rapid Detection of Foot-and-Mouth Disease Virus

Evaluation of Human Enterovirus 71 and Coxsackievirus A16 Specific Immunoglobulin M Antibodies for Diagnosis of Hand-Foot-and-mouth Disease

Rapid detection of four major HFMD-associated enteroviruses by multiplex HiFi-LAMP assays

Preparation of probes to detect human enterovirus, enterovirus 71, and coxsackievirus A16